Mei Dong
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 5%
- Hematology top 5%
- Pathology and Forensic Medicine top 10%
- Co-authors
- Gerard C. BlobeTam HowKelly J. GordonNadine HempelTimothy A. FieldsXianping LuZhiqiang NingMichael Newman
- Topics
- TGF-β signaling in diseases (8 papers)MicroRNA in disease regulation (5 papers)Histone Deacetylase Inhibitors Research (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Mei Dong
35 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 1.2k
- Oncology 539
- Cancer Research 332
- Hematology 167
- Pathology and Forensic Medicine 159
Countries citing papers authored by Mei Dong
This map shows the geographic impact of Mei Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Dong more than expected).
Fields of papers citing papers by Mei Dong
This network shows the impact of papers produced by Mei Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Dong. The network helps show where Mei Dong may publish in the future.
Co-authorship network of co-authors of Mei Dong
This figure shows the co-authorship network connecting the top 25 collaborators of Mei Dong. A scholar is included among the top collaborators of Mei Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Dong. Mei Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 8 | |
| 5 | 27 | |
| 6 | 8 | |
| 7 | 12 | |
| 8 | 58 | |
| 9 | 22 | |
| 10 | 17 | |
| 11 | 21 | |
| 12 | 171 | |
| 13 | 90 | |
| 14 | 221 | |
| 15 | 102 | |
| 16 | 96 | |
| 17 | 108 | |
| 18 | 204 | |
| 19 | 11 | |
| 20 | 20 |
About Mei Dong
Mei Dong is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 36 papers that have together received 1.7k indexed citations. Recurring topics across this work include TGF-β signaling in diseases (8 papers), MicroRNA in disease regulation (5 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Cancer Research (332 citations), Oncology (539 citations) and Molecular Biology (1.2k citations). Mei Dong has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Gerard C. Blobe, Tam How, Kelly J. Gordon, Nadine Hempel, Timothy A. Fields, Xianping Lu, Zhiqiang Ning, Michael Newman, Song Shan and Xinhao Wang. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.